About Christopher Yaen
Form D filings for Deka Biosciences in 2023 list Christopher Yaen as executive officer.
Christopher Yaen first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Yaen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Yaen works with at each company, as listed on that company's latest Form D.
Deka Biosciences, Inc. · Form D, Dec 8, 2023
JM
John Mumm
Chief Executive Officer and director
PK
Pavel Khrimian
Executive officer
DB
Detlev Biniszkiewicz
Director
LH
Lu Han
Director
Rakhshita Dhar
Director
PB
Peter Buzy
Director